{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:14:09Z","timestamp":1790421249214,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jocn.2025.111824","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:52:26Z","timestamp":1766487146000},"page":"111824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["No differences in the proportions of immune cells in CSF of patients with neurosarcoidosis and multiple sclerosis"],"prefix":"10.1016","volume":"144","author":[{"given":"Angie H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo A.","family":"Arbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jocn.2025.111824_b0005","first-page":"e1905","article-title":"Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis","volume":"94","author":"Arun","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.jocn.2025.111824_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577849","article-title":"Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis","volume":"367","author":"Byg","year":"2022","journal-title":"J Neuroimmunol."},{"issue":"9","key":"10.1016\/j.jocn.2025.111824_b0015","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/ene.13975","article-title":"The cerebrospinal fluid CD4\/CD8 ratio and interleukin\u20116 and \u201110 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study","volume":"26","author":"Chazal","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2025.111824_b0020","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Zapata C, Otto C, Gallaccio G, Chen Q, Wang M, Uluvar B, et al. Comprehensive cerebrospinal fluid analysis indicates key roles for B cells in multiple sclerosis. medRxiv. 2025 Jan 2. doi:10.1101\/2025.01.02.24319302.","DOI":"10.1101\/2025.01.02.24319302"},{"key":"10.1016\/j.jocn.2025.111824_b0025","article-title":"Cerebrospinal fluid immune cells in neurosarcoidosis show a distinct CD4+ T cell\u2013dominated profile","volume":"339","author":"Heming","year":"2020","journal-title":"Journal of Neuroimmunology"},{"issue":"11","key":"10.1016\/j.jocn.2025.111824_b0030","article-title":"Sarcoidosis Epidemiology: Race Matters","volume":"15","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2025.111824_b0035","doi-asserted-by":"crossref","unstructured":"Hutto SK, Balaban D, Rohm Z, et al. Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study. J Neurol. 2025;272(8):519. Published 2025 Jul 18. doi:10.1007\/s00415-025-13209-7.","DOI":"10.1007\/s00415-025-13209-7"},{"key":"10.1016\/j.jocn.2025.111824_b0040","article-title":"The CSF in neurosarcoidosis contains consistent clonal expansion of CD4+ T cells","volume":"370","author":"Khaiboullina","year":"2022","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"10.1016\/j.jocn.2025.111824_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/CPJ.0000000000001105","article-title":"How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race\/Ethnicity","volume":"11","author":"Kister","year":"2021","journal-title":"Neurol Clin Pract."},{"key":"10.1016\/j.jocn.2025.111824_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578394","article-title":"Beyond biopsy for neurosarcoidosis: A review of blood and CSF biomarkers","volume":"393","author":"Lackey","year":"2024","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.jocn.2025.111824_b0055","doi-asserted-by":"crossref","unstructured":"Lenercept Multiple Sclerosis Study Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group.Neurology. 1999;53(3):457-465.","DOI":"10.1212\/WNL.53.3.457"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111824_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"Journal of Neuroimmunology"},{"issue":"1","key":"10.1016\/j.jocn.2025.111824_b0065","first-page":"5987","article-title":"A comprehensive diagnostic approach in suspected neurosarcoidosis","volume":"13","author":"Marangoni","year":"2023","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.jocn.2025.111824_b0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ane.13297","article-title":"Cerebrospinal fluid CD4+\/CD8+ ratio in diagnosing neurosarcoidosis","volume":"142","author":"Nordstr\u00f6m","year":"2020","journal-title":"Acta Neurol Scand."},{"issue":"10","key":"10.1016\/j.jocn.2025.111824_b0075","first-page":"1964","article-title":"The cerebrospinal fluid CD4\/CD8 ratio and interleukin-6 and -10 are elevated in neurosarcoidosis","volume":"27","author":"Roesler","year":"2020","journal-title":"European Journal of Neurology"},{"issue":"12","key":"10.1016\/j.jocn.2025.111824_b0080","first-page":"3069","article-title":"CSF glucose and lactate levels in inflammatory, infectious, and other neurological disorders: A comparative study","volume":"266","author":"Schwenkenbecher","year":"2019","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1016\/j.jocn.2025.111824_b0085","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jocn.2025.111824_b0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jocn.2025.111824_b0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1212\/CPJ.0000000000000629","article-title":"Multiple sclerosis and sarcoidosis: A case for coexistence","volume":"9","author":"Tyshkov","year":"2019","journal-title":"Neurol Clin Pract."},{"key":"10.1016\/j.jocn.2025.111824_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1135392","article-title":"Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction","volume":"14","author":"Vlad","year":"2023","journal-title":"Front Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825007970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825007970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:37:57Z","timestamp":1767425877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825007970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":20,"alternative-id":["S0967586825007970"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111824","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No differences in the proportions of immune cells in CSF of patients with neurosarcoidosis and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111824"}}